BET-inhibition with Apabetalone in Post-ACS Patients with Diabetes: Design and Baseline Characteristics of the BETonMACE trial

Ray, KK; Nicholls, SJ; Sweeney, M; Johansson, J; Wong, N; Kulikowski, E; Toth, P; Ginsberg, H; Kalantar-Zadeh, K; Schwartz, GG

EUROPEAN HEART JOURNAL, 2019; 40 (): 2819